173 related articles for article (PubMed ID: 12751207)
61. Detection of EBV and HPV in nasopharyngeal carcinoma by in situ hybridization.
Mirzamani N; Salehian P; Farhadi M; Tehran EA
Exp Mol Pathol; 2006 Dec; 81(3):231-4. PubMed ID: 16787643
[TBL] [Abstract][Full Text] [Related]
62. [Detection of Epstein-Barr virus gene in nasopharyngeal carcinoma with neck lymphatic metastasis].
Li J; Li Q; Li R
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Dec; 13(4):377-9. PubMed ID: 12759983
[TBL] [Abstract][Full Text] [Related]
63. New BZLF1 sequence variations in EBV-associated undifferentiated nasopharyngeal carcinoma in southern China.
Ji KM; Li CL; Meng G; Han AD; Wu XL
Arch Virol; 2008; 153(10):1949-53. PubMed ID: 18807115
[TBL] [Abstract][Full Text] [Related]
64. Plasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinoma.
Leung SF; Zee B; Ma BB; Hui EP; Mo F; Lai M; Chan KC; Chan LY; Kwan WH; Lo YM; Chan AT
J Clin Oncol; 2006 Dec; 24(34):5414-8. PubMed ID: 17135642
[TBL] [Abstract][Full Text] [Related]
65. Molecular diagnosis of nasopharyngeal carcinoma using detection of Epstein-Barr virus latent membrane protein-1 gene in cervical metastatic lymph nodes.
Khademi B; Mahmoudi J; Monabati A; Maghsoudi B; Ashraf MJ; Mohammadianpanah M; Tabibi N; Valibeigi B; Abedi E
Am J Otolaryngol; 2009; 30(2):95-100. PubMed ID: 19239950
[TBL] [Abstract][Full Text] [Related]
66. [The value of polymerase chain reaction on Epstein-Barr virus subtypes in the differentiation of benign and malignant nasopharyngeal biopsies].
Sun N; Chen X
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(4):213-5. PubMed ID: 8745459
[TBL] [Abstract][Full Text] [Related]
67. Epstein-Barr virus DNA quantification and follow-up in Tunisian nasopharyngeal carcinoma patients.
Hassen E; Farhat K; Gabbouj S; Bouaouina N; Abdelaziz H; Chouchane L
Biomarkers; 2011 May; 16(3):274-80. PubMed ID: 21506698
[TBL] [Abstract][Full Text] [Related]
68. Quantitative analysis of cell-free Epstein-Barr virus DNA in the plasma of patients with peripheral T-cell and NK-cell lymphomas and peripheral T-cell proliferative diseases.
Suwiwat S; Pradutkanchana J; Ishida T; Mitarnun W
J Clin Virol; 2007 Dec; 40(4):277-83. PubMed ID: 17996493
[TBL] [Abstract][Full Text] [Related]
69. Rapid clearance of plasma Epstein-Barr virus DNA after surgical treatment of nasopharyngeal carcinoma.
To EW; Chan KC; Leung SF; Chan LY; To KF; Chan AT; Johnson PJ; Lo YM
Clin Cancer Res; 2003 Aug; 9(9):3254-9. PubMed ID: 12960110
[TBL] [Abstract][Full Text] [Related]
70. Clinical applications of plasma Epstein-Barr virus DNA analysis and protocols for the quantitative analysis of the size of circulating Epstein-Barr virus DNA.
Chan KC; Lo YM
Methods Mol Biol; 2006; 336():111-21. PubMed ID: 16916257
[TBL] [Abstract][Full Text] [Related]
71. Overexpression of Epstein-Barr virus-encoded microRNA-BART7 in undifferentiated nasopharyngeal carcinoma.
Chan JY; Gao W; Ho WK; Wei WI; Wong TS
Anticancer Res; 2012 Aug; 32(8):3201-10. PubMed ID: 22843893
[TBL] [Abstract][Full Text] [Related]
72. Epstein-Barr virus (EBV)-encoded BARF1 gene is expressed in nasopharyngeal carcinoma and EBV-associated gastric carcinoma tissues in the absence of lytic gene expression.
Seto E; Yang L; Middeldorp J; Sheen TS; Chen JY; Fukayama M; Eizuru Y; Ooka T; Takada K
J Med Virol; 2005 May; 76(1):82-8. PubMed ID: 15778977
[TBL] [Abstract][Full Text] [Related]
73. [Detection of EBV by PCR in fresh and paraffin embedded samples of cavum tumour].
Charef S; Jrad BB; Mahfouth W; Zakhama A; Kassab A; Driss N; Chouchane L
Arch Inst Pasteur Tunis; 2006; 83(1-4):41-7. PubMed ID: 19388596
[TBL] [Abstract][Full Text] [Related]
74. Epstein-Barr virus encoded BALF1 gene is transcribed in Burkitt's lymphoma cell lines and in nasopharyngeal carcinoma's biopsies.
Cabras G; Decaussin G; Zeng Y; Djennaoui D; Melouli H; Broully P; Bouguermouh AM; Ooka T
J Clin Virol; 2005 Sep; 34(1):26-34. PubMed ID: 16087121
[TBL] [Abstract][Full Text] [Related]
75. Salivary Epstein-Barr virus DNA level in patients with nasopharyngeal carcinoma following radiotherapy.
Pow EH; Law MY; Tsang PC; Perera RA; Kwong DL
Oral Oncol; 2011 Sep; 47(9):879-82. PubMed ID: 21767975
[TBL] [Abstract][Full Text] [Related]
76. Comparison of a LightCycler-based real-time PCR for quantitation of Epstein-Barr viral load in different clinical specimens with semiquantitative PCR.
Krumbholz A; Meerbach A; Zell R; Gruhn B; Henke A; Birch-Hirschfeld E; Wutzler P
J Med Virol; 2006 May; 78(5):598-607. PubMed ID: 16555269
[TBL] [Abstract][Full Text] [Related]
77. Application of circulating plasma/serum EBV DNA in the clinical management of nasopharyngeal carcinoma.
Yip TT; Ngan RK; Fong AH; Law SC
Oral Oncol; 2014 Jun; 50(6):527-38. PubMed ID: 24440146
[TBL] [Abstract][Full Text] [Related]
78. [Comparison of Epstein-Barr virus in nasopharynx tissue and desquamatine cell for diagnosis of nasopharyngeal carcinoma].
Sun Z; Xiao C; Jiang W; Feng X; Liu Y
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Feb; 20(4):153-4. PubMed ID: 16711437
[TBL] [Abstract][Full Text] [Related]
79. Epstein-Barr virus serology in early detection and screening of nasopharyngeal carcinoma.
Ng MH; Chan KH; Ng SP; Zong YS
Ai Zheng; 2006 Feb; 25(2):250-6. PubMed ID: 16480597
[TBL] [Abstract][Full Text] [Related]
80. Does Epstein-Barr virus play a role in lymphoepithelioma-like carcinoma of the uterine cervix?
Chao A; Tsai CN; Hsueh S; Lee LY; Chen TC; Huang SL; Chao FY; Lai CH
Int J Gynecol Pathol; 2009 May; 28(3):279-85. PubMed ID: 19620947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
